[1] Parkinson's disease and Movement Disorders Group, Neurology Branch, Chinese Medical Association; Parkinson's Disease and Movement Disorders Committee, Neurology Branch, Chinese Medical Doctor Association. Diagnostic criteria for Parkinson's disease in China (2016 edition)[J]. Zhonghua Shen Jing Ke Za Zhi, 2016, 49:268-271.[中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会.中国帕金森病的诊断标准(2016版)[J].中华神经科杂志, 2016, 49:268-271.] [2] LeWitt PA, Kymes S, Hauser RA. Parkinson disease and orthostatic hypotension in the elderly:recognition and management of risk factors for falls[J]. Aging Dis, 2020, 11:679-691. [3] Palma JA, Kaufmann H. Orthostatic hypotension in Parkinson disease[J]. Clin Geriatr Med, 2020, 36:53-67. [4] Tzur I, Izhakian S, Gorelik O. Orthostatic hypotension:definition, classification and evaluation[J]. Blood Press, 2019, 28:146-156. [5] Aydin AE, Soysal P, Isik AT. Which is preferable for orthostatic hypotension diagnosis in older adults:active standing test or head-up tilt table test[J]?Clin Interv Aging, 2017, 12:207-212. [6] Liu XD, Tian YL, Si HN. Evaluation of olfactory function and related factors in patients with Parkinson's disease[J].Zhongguo Shen Jing Mian Yi Xue He Shen Jing Bing Xue Za Zhi, 2019, 26:196-200.[刘香丹,田玉玲,司海娜.帕金森病患者嗅觉障碍及其相关因素分析[J].中国神经免疫学和神经病学杂志, 2019, 26:196-200.] [7] Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease[J]. Mov Disord, 2010, 25:2649-2653. [8] Li LX, Lian TH, Guo P, Ding DY, Li DN, Zhang WJ, Guan HY, Gao JH, Zhang W. Parkinson's disease combined with orthostatic hypotension:characteristics and its effects on cognitive function[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2020, 39:1001-1005.[李丽霞,连腾宏,郭鹏,丁杜宇,李丹凝,张伟娇,关惠盈,高俊华,张巍.帕金森病患者伴发体位性低血压的特点及其对认知功能的影响[J].中华老年医学杂志, 2020, 39:1001-1005.] [9] Ye JN, Gao YX. Clinical progress of vertical tilt test[J]. Zhong Feng Yu Shen Jing Ji Bing Za Zhi, 2017, 34:1047-1049.[叶静纳,高雅萱.直立倾斜试验的临床研究进展[J].中风与神经疾病杂志, 2017, 34:1047-1049.] [10] Zhou PX, Li SQ. Research progress in orthostatic hypotension with Parkinson's disease[J]. Zhonghua Quan Ke Yi Xue, 2018, 16:113-117.[周沛萱,李双庆,帕金森病患者直立性低血压的研究进展[J].中华全科医学, 2018, 16:113-117.] [11] Tang JJ. Application and comparison of Montreal Cognitive Assessment and Mini-Mental State Examination in the screening of cognitive impairment[J]. Shi Yong Yi Yuan Lin Chuang Za Zhi, 2011, 8:193-195.[唐娟娟.蒙特利尔认知评估量表与简易精神状态量表在认知功能障碍筛查中的应用与比较[J].实用医院临床杂志, 2011, 8:193-195.] [12] Neurology Branch, Chinese Medical Association; Sleep Disorders Group, Neurology Branch, Chinese Medical Association; Neuropsychological and Behavioral Neuropathy Group, Neurology Branch, Chinese Medical Association. Expert consensus on the diagnosis and treatment of insomnia with depression and anxiety in Chinese adults[J]. Zhonghua Shen Jing Ke Za Zhi, 2020, 53:564-574.[中华医学会神经病学分会,中华医学会神经病学分会睡眠障碍学组,中华医学会神经病学分会神经心理与行为神经病学学组.中国成人失眠伴抑郁焦虑诊治专家共识[J].中华神经科杂志, 2020, 53:564-574.] [13] Wei Y, Yang XD, Lan HB, Fan WB, Wang LN. Joint interpretation of 2017 edition of expert consensus on classification and clinical strategy of constipation and guide for surgical diagnosis and treatment of constipation (2017 edition)[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2020, 23:1220-1222.[魏雨,杨向东,蓝海波,樊文彬,汪丽娜.《2017版便秘的分度与临床策略专家共识》与《便秘外科诊治指南》联合解读[J].中华胃肠外科杂志, 2020, 23:1220-1222.] [14] Hu X, Bian WT, Yan FL, Liu WG. Postural hypotension in patients with Parkinson's disease[J]. Lin Chuang Shen Jing Bing Xue Za Zhi, 2012, 25:388-390.[胡晓,卞玮婷,闫福岭,刘卫国.帕金森病患者的体位性低血压[J].临床神经病学杂志, 2012, 25:388-390.] [15] Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension[J]. Eur J Neurol, 2006, 13:930-936. [16] Mao YD, Xing K. Research progress in risk factors and pathogenesis of orthostatic hypotension[J]. Zhongguo Xin Xue Guan Za Zhi, 2019, 24:587-589.[毛引弟,邢坤.体位性低血压的危险因素及发病机制研究进展[J].中国心血管杂志, 2019, 24:587-589.] [17] Wu Y, Xu MZ, Ming XX, Shi LF, Gong KZ, Zhang ZG, Zhang K. Comparison of the detection results of head-up tilt test and recumbent-upright test on orthostatic hypotension in elderly hypertension patients[J]. Zhonghua Xin Zang Yu Xin Lü Dian Zi Za Zhi, 2019, 7:135-137.[伍勇,徐敏芝,明小星,石留芬,龚开政,张振刚,张可.直立倾斜试验与卧立位试验对老年高血压患者体位性低血压的检出效果比较[J].中华心脏与心律电子杂志, 2019, 7:135-137.] [18] Wang ZC, Ji WH. Research progress in study of orthostatic hypotension[J]. Shanghai Yi Yao, 2015, 36:22-27.[王占成,姬文慧.体位性低血压的研究进展[J].上海医药, 2015, 36:22-27.] [19] Fereshtehnejad SM, L?kk J. Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism[J].Parkinsons Dis, 2014:ID475854. [20] Hiorth YH, Pedersen KF, Dalen I, Tysnes OB, Alves G. Orthostatic hypotension in Parkinson disease:a 7-year prospective population-based study[J]. Neurology, 2019, 93:e1526-1534. [21] Huang JY, Chen J, Zhao XY, Jin H, Mao CJ, Zheng HF, Liu CF. Incidence of orthostatic hypotension in patients with Parkinson's disease and its related factors[J]. Shi Yong Lao Nian Yi Xue, 2019, 33:1052-1055.[黄隽英,陈静,赵晓芸,金宏,毛成洁,郑慧芬,刘春风.帕金森病病人体位性低血压的发生率及其相关因素分析[J].实用老年医学, 2019, 33:1052-1055.] [22] Longardner K, Bayram E, Litvan I. Orthostatic hypotension is associated with cognitive decline in Parkinson disease[J]. Front Neurol, 2020, 11:897. [23] Oka H, Yoshioka M, Onouchi K, Morita M, Mochio S, Suzuki M, Hirai T, Ito Y, Inoue K. Characteristics of orthostatic hypotension in Parkinson's disease[J]. Brain, 2007, 130(Pt 9):2425-2432. [24] Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease:evidence from 3 cases[J]?Mov Disord, 2012, 27:716-719. [25] Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease[J]. Lancet Neurol, 2015, 14:625-639. [26] Bocti C, Pépin F, Tétreault M, Cossette P, Langlois F, Imbeault H, Duval N, Lacombe G, Fulop T. Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment[J]. J Neurol Sci, 2017, 382:79-83. [27] Ma HM, Ma SH. Autonomic dysfuction and its correlation research in patients with Parkinson's disease combined with orthostatic hypotension[J]. Lin Chuang Shen Jing Bing Xue Za Zhi, 2019, 32:337-340.[麻红梅,麻守花.帕金森病合并体位性低血压患者自主神经功能情况及相关性研究[J].临床神经病学杂志, 2019, 32:337-340.] [28] Robertson AD, Udow SJ, Espay AJ, Merola A, Camicioli R, Lang AE, Masellis M. Orthostatic hypotension and dementia incidence:links and implications[J]. Neuropsychiatr Dis Treat, 2019, 15:2181-2194. [29] Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease[J]. Neurobiol Aging, 2003, 24:197-211. [30] McDonald C, Newton JL, Burn DJ. Orthostatic hypotension and cognitive impairment in Parkinson's disease:causation or association[J]?Mov Disord, 2016, 31:937-946. [31] Peters R, Anstey KJ, Booth A, Beckett N, Warwick J, Antikainen R, Rockwood K, Peters J, Bulpitt CJ. Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment:an integrated evidence review and analysis of a large older adult hypertensive cohort[J]. Eur Heart J, 2018, 39:3135-3143. [32] Umehara T, Matsuno H, Toyoda C, Oka H. Clinical characteristics of supine hypertension in de novo Parkinson disease[J]. Clin Auton Res, 2016, 26:15-21. [33] Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension[J]. J Neurol, 2017, 264:1567-1582. [34] Jordan J, Fanciulli A, Tank J, Calandra-Buonaura G, Cheshire WP, Cortelli P, Eschlboeck S, Grassi G, Hilz MJ, Kaufmann H, Lahrmann H, Mancia G, Mayer G, Norcliffe-Kaufmann L, PavyLe Traon A, Raj SR, Robertson D, Rocha I, Reuter H, Struhal W, Thijs RD, Tsioufis KP, Gert van Dijk J, Wenning GK, Biaggioni I. Management of supine hypertension in patients with neurogenic orthostatic hypotension:scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension[J]. J Hypertens, 2019, 37:1541-1546. [35] Wang KL, Yu HM, Luo XG, Zhao ZY, Wu Z. Research progress of blood pressure characteristics and mechanism in Parkinson's disease[J]. Guo Ji Shen Jing Bing Xue Shen Jing Wai Ke Xue Za Zhi, 2020, 47:103-106.[王库良,禹红梅,罗晓光,赵作元,吴哲.帕金森患者的血压特点及其机制的研究进展[J].国际神经病学神经外科学杂志, 2020, 47:103-106.] |